China Shineway Pharmaceutical Group (HKSE:02877) Ending Cash Position : HK$6,441 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is China Shineway Pharmaceutical Group Ending Cash Position?

China Shineway Pharmaceutical Group's Ending Cash Position for the quarter that ended in Dec. 2023 was HK$6,441 Mil.

China Shineway Pharmaceutical Group's quarterly Ending Cash Position increased from Dec. 2022 (HK$5,613 Mil) to Jun. 2023 (HK$5,868 Mil) and increased from Jun. 2023 (HK$5,868 Mil) to Dec. 2023 (HK$6,441 Mil).

China Shineway Pharmaceutical Group's annual Ending Cash Position increased from Dec. 2021 (HK$5,150 Mil) to Dec. 2022 (HK$5,613 Mil) and increased from Dec. 2022 (HK$5,613 Mil) to Dec. 2023 (HK$6,441 Mil).

China Shineway Pharmaceutical Group Ending Cash Position Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Ending Cash Position Chart

China Shineway Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

4,390.92

4,674.17

5,149.77

5,612.90

6,441.02

China Shineway Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															5,149.77	5,229.41	5,612.90	5,867.67	6,441.02

China Shineway Pharmaceutical Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

China Shineway Pharmaceutical Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5497.623	+	943.396
	=	6,441

China Shineway Pharmaceutical Group's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5867.66	+	573.359
	=	6,441

China Shineway Pharmaceutical Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

China Shineway Pharmaceutical Group (HKSE:02877) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (HKSE:02877) » Definitions » Ending Cash Position

Traded in Other Exchanges

C1S:Germany

Address

Luan Cheng, Hebei Province, Shijiazhuang, CHN

Website

http://www.shineway.com.hk

China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

Executives

Bh Corporate Services Ltd	2301 Trustee
Bodnar-horvath Kwai Yung Helen	2202 Interest of your spouse
Bodnar-horvath Nicholas Eugene Francis	2201 Interest of corporation controlled by you
Forway Investment Limited	2101 Beneficial owner
Li Zhenjiang	2307 Founder of a discretionary trust who can infl

China Shineway Pharmaceutical Group (HKSE:02877) Headlines

No Headlines